The long noncoding RNA LINC00200 promotes the malignant progression of MYCN-amplified neuroblastoma via binding to insulin like growth factor 2 mRNA binding protein 3 (IGF2BP3) to enhance the stability of Zic family member 2 (ZIC2) mRNA

Abstract

ObjectivesNeuroblastoma (NB) is one of the most common extracranial malignant tumors in children and remarkable heterogeneous tumor of the sympathetic nervous system. Long noncoding RNAs (lncRNAs) have been reported to be vital biological roles in the initiation and malignant progression of tumors. The aim of this study was to explore the biological role and the possible molecular mechanism of LINC00200 in NB. Design & methodsThe expression level of LINC00200 in NB tissues and cell lines were detected by real-time quantitative PCR (qRT-PCR). The biological effects of LINC00200 on NB cell proliferation, migration and invasion were examined by EdU and transwell assays. The molecular mechanism of LINC00200 in NB were explored and verified by bioinformatics analysis, RNA binding protein immunoprecipitation (RIP) assay and RNA pull down assay. ResultsThe results showed that the expression of LINC00200 was significantly higher in NB tissues than in normal tissues. Besides, the expression of LINC00200 was higher in MYCN Amplified NB tissues than in MYCN non-Amplified NB tissues. Moreover, overexpression of LINC00200 could remarkedly promote proliferation, migration and invasion of NB cell. Mechanistically, LINC00200 might bind to RNA binding protein (RBP) IGF2BP3 and promote the expression of ZIC2. ConclusionsOverall, we showed that LINC00200 was upregulated in NB tissues and the LINC00200/IGF2BP3/ZIC2 regulatory axis might be the possible therapeutic target for NB.